<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-AFSA-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact against Tuberculosis and HIV - South Africa (01-Apr-2016-31-Mar-2019)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, AIDS Foundation South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Ensuring an enabling and accessible legal framework that protects and promotes human rights in order to support implementation of the NSP; Initiating at least 80% of eligible patients on antiretroviral treatment, with 70% alive and on treatment five years after initiation; Reducing new HIV infections by at least 50%, using combination prevention approaches; Reducing self-reported stigma related to HIV and TB by at least 50%; Reducing the number of new TB infections and deaths from TB by 50%. Objectives: Addressing Social and Structural Drivers of HIV and TB Prevention, Care and Impact; Ensuring protection of human rights and improving access to justice; Preventing New HIV, STI and TB Infections; Sustaining Health and Wellness.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-AFSAP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-04-01" />
    <activity-date type="2" iso-date="2016-04-01" />
    <activity-date type="3" iso-date="2019-03-31" />
    <activity-date type="4" iso-date="2019-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="a6b6413e-4023-41c8-bdc2-11647e0ad50b">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-09" />
      <value currency="USD" value-date="2016-05-09">6650111.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8e5cbf0-e59e-4d3e-90db-787a0479a47e">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-10" />
      <value currency="USD" value-date="2016-05-10">1177351.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8dfec8cd-8b5a-4d5b-ade2-0fa881f7a074">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-08-23" />
      <value currency="USD" value-date="2016-08-23">601092.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0980dd7f-4102-4aa4-ab86-6b0e9b758c60">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-15" />
      <value currency="USD" value-date="2016-11-15">1114677.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e82e6726-1a63-49de-bc4e-6bc54fb37b6f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-02" />
      <value currency="USD" value-date="2017-02-02">741905.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="376a8f1e-4b57-47ae-8ab9-16c1a22dd28d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-04-13" />
      <value currency="USD" value-date="2017-04-13">2270585.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1a4bf144-62d3-433c-a3ff-f7d573b4864a">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">744501.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2a84b9d-46fc-4569-ae6e-98b10f486211">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-10-03" />
      <value currency="USD" value-date="2017-10-03">1056839.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="37b8866d-ab57-467f-9c86-68003ed5892c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-05" />
      <value currency="USD" value-date="2017-10-05">1056839.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be5baed3-540d-48a2-b703-78c781b5d7af">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-30" />
      <value currency="USD" value-date="2017-11-30">4071926.63</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd419dc3-5635-4134-bc3f-e1655aedeb6d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-01" />
      <value currency="USD" value-date="2017-12-01">647830.63</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cae55a60-5d6a-436c-88bb-c2dce3cb7aca">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-30" />
      <value currency="USD" value-date="2018-01-30">1782050.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="27b15f06-84f6-4635-bde1-07fe2ba0a905">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-19" />
      <value currency="USD" value-date="2018-04-19">1431432.52</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="194edb94-6ddb-44c3-aadc-1dcaf3eca23c">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-30" />
      <value currency="USD" value-date="2018-07-30">1648945.54</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd72d8ea-1352-444d-9726-cc1035c9e827">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-30" />
      <value currency="USD" value-date="2018-07-30">-210613.48</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c470ed8d-68ab-4086-8a09-d64f63af2a27">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-31" />
      <value currency="USD" value-date="2018-07-31">1648945.54</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a16d0c37-c62e-4fcf-aa45-7a066207087e">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-09-20" />
      <value currency="USD" value-date="2018-09-20">2384945.39</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33f44d11-e7eb-4e94-b630-6b5d0eca407a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-09-21" />
      <value currency="USD" value-date="2018-09-21">2384945.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="187d81db-d370-4794-a5b9-80af3e3dabfe">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">2560247.41</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a32a703-b304-40fa-8eb2-6db9d1407aec">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-01" />
      <value currency="USD" value-date="2019-02-01">1587568.08</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9f19e086-43e9-4c0d-a442-fbbbf0676a68">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-09" />
      <value currency="USD" value-date="2019-05-09">170119.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f895f6bb-d122-4be7-95fd-6d66d3bf19d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-04-29" />
      <value currency="USD" value-date="2020-04-29">-802560.33</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-AFSA-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2019-31-Mar-2022)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, AIDS Foundation South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Reach all key and vulnerable populations with customised and targeted interventions; Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: 1.1 Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions; 2.1 Implement the 90-90-90 strategy for HIV; 2.2 Implement the 90-90-90 Strategy for TB; 3.1 Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities; 3.2 To provide an enabling environment to increase access to health services by key and vulnerable populations; 4.1 Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion; 4.4 Implement and scale up a package of harm reduction interventions for harmful use of alcohol and drugs in all districts; 4.5 Implement economic strengthening programmes with a focus on youth in priority focus districts; 5.3 Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; 6.1 Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; 7.1 Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; 8.1 Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-AFSAP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-04-01" />
    <activity-date type="2" iso-date="2019-04-01" />
    <activity-date type="3" iso-date="2022-03-31" />
    <activity-date type="4" iso-date="2022-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="68.6">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="31.4">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="732c3707-c5a2-4b8c-9650-f713d3a87712" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
        </description>
      </budget-item>
      <budget-item code="02835168-3d6f-499f-b99f-10c2ddee5f1c" percentage="1.84">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Addressing stigma, discrimination and legal barriers to care for adolescents and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="a043623f-0c87-42d4-8d1a-14144145ecb6" percentage="12.46">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="7460fcfb-c606-41d9-ab9e-e457af0710fd" percentage="3.97">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Gender-based violence prevention and treatment programs for adolescents and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="01b3eb9e-75bd-47fc-833d-1b5266368425" percentage="5.88">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; HIV testing services for adolescents and youth, in and out of school</narrative>
        </description>
      </budget-item>
      <budget-item code="6dbca3a1-2166-42e6-89a3-dccb7ecfcb04" percentage="6">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Keeping girls in school</narrative>
        </description>
      </budget-item>
      <budget-item code="5d5f8117-e506-48aa-a2c4-b26999f788b0" percentage="6.07">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Linkages of HIV, RMNCH, and TB programs for adolescents, girls, and young women</narrative>
        </description>
      </budget-item>
      <budget-item code="9548700f-d4e0-4aa8-b1f6-ebd43a163444" percentage="9.62">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Other intervention(s) for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="0ccb63f1-1008-459f-9ab1-43e4ff92c43e" percentage="4.32">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Pre-exposure prophylaxis (PrEP) for adolescents and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="bacec71a-3986-414a-b135-8dd9b691c25a" percentage="5.41">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Socioeconomic approaches</narrative>
        </description>
      </budget-item>
      <budget-item code="f656ae4a-0f86-4a63-bf7a-8dce1eda4edd" percentage="1.99">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="557c641d-d721-482b-a47f-096caa882957" percentage="0.74">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="58c0b914-97aa-48f7-a852-b18c3835a345" percentage="3.68">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="dd23042c-9916-42f5-9c9c-f89101c2bb28" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="48484293-8d88-4a4d-ac0d-6ea012152220" percentage="1.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="27cc825e-cdd6-4725-8a33-53f5a933b287" percentage="5.45">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.17">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="17.2">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd90b50-0924-481f-b5a1-22b7305b5dbb" percentage="5.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="04ad0584-b1dd-4ef6-ac1e-dad3669a97d1" percentage="4.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="1.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="3.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">7391667.88</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">46964825.40</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">17008840.94</value>
    </budget>
    <capital-spend percentage="4.29" />
    <transaction ref="89ca9fac-6b80-41e9-a605-a7d9a06b6102">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-23" />
      <value currency="USD" value-date="2019-05-23">27906855.82</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="598cebff-2030-46cc-ae04-5052daca0689">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-24" />
      <value currency="USD" value-date="2019-05-24">3016642.85</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aa2aa23c-4c10-4692-ba1f-a207644fdab9">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-12" />
      <value currency="USD" value-date="2019-09-12">4578932.12</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="43d00a4a-a377-4c9c-b687-d1807cafab6a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-21" />
      <value currency="USD" value-date="2020-02-21">1349005.23</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d06e5400-0c14-4d1e-a43b-5bdd7515c05e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">3680841.32</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c49703c7-c814-49d2-b183-df57f3c54978">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-29" />
      <value currency="USD" value-date="2020-07-29">4683490.65</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fe33a5db-6e47-47e7-868b-c01792e0fcac">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-16" />
      <value currency="USD" value-date="2020-11-16">23297816.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="44830c2f-378b-4ca3-9c5a-8a53f62f4053">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-16" />
      <value currency="USD" value-date="2020-11-16">-10597943.65</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b552a3c2-dc02-4c40-ad48-cce6d0264896">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-19" />
      <value currency="USD" value-date="2020-11-19">6489478.34</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e38b54fd-4608-4d12-b73a-cbeb850fb770">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">4779743.33</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="59022b53-1148-4db2-a678-b4efbd28d2db">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-01" />
      <value currency="USD" value-date="2021-06-01">10131184.52</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e571f8f7-68e3-4875-bcc6-33172588e9ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-1897409.81</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0ff0752-93c3-4bcf-801e-972229a9aa05">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">26687739.21</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db9bc63d-8cac-4061-b488-6b9b2c46c0e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">2130467.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bb8abca-238a-43bb-8330-b9a464375e42">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">6154571.11</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6dc35b1-0f31-4158-a343-145061b989b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-13" />
      <value currency="USD" value-date="2022-01-13">2956667.54</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="59847404-16fa-4b1e-835a-d1a2439af7a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-13" />
      <value currency="USD" value-date="2022-01-13">5783776.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b070791b-4139-425f-8682-1af882e09f69">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-14" />
      <value currency="USD" value-date="2022-04-14">360203.91</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c1b788d-20ed-48ba-8791-993a7a2d2945">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-14" />
      <value currency="USD" value-date="2022-04-14">2651001.69</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="350f9af0-2e35-412e-a2b4-b805a9a12c9b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-05" />
      <value currency="USD" value-date="2022-05-05">4513083.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1a17cbdf-365e-4d69-973e-7cce468d12bb">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-11-09" />
      <value currency="USD" value-date="2023-11-09">113155.66</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cb62b393-0798-450c-bd0f-1b383798dc23">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-17" />
      <value currency="USD" value-date="2023-11-17">-113155.66</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fb208783-d0e5-4bc7-bfb8-466a2718ed52">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">559952.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2d67b18-6f18-4d81-92dc-ddf600065931">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">1578015.74</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ef1f9e18-dc4c-491c-8d2a-d54e96bc6b2a">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-11-14" />
      <value currency="USD" value-date="2024-11-14">50643.93</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-AFSAP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49e2c9d7-337c-4307-9184-9332407d733d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-18" />
      <value currency="USD" value-date="2024-11-18">-50643.93</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP02-EXP-20200331">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-03-31" />
      <value currency="USD" value-date="2020-03-31">8145706.27</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP02, Apr 2019 to Mar 2020.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP02-EXP-20210331">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-03-31" />
      <value currency="USD" value-date="2021-03-31">16828133.00</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP02, Apr 2020 to Mar 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP02-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">32760524.11</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP02, Apr 2021 to Mar 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP02-EXP-20220930">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-09-30" />
      <value currency="USD" value-date="2022-09-30">714204.10</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP02, Apr 2022 to Sep 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of adolescent girls and young women (AGYW) who were tested for HIV and received their results during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for adolescents and youth, in and out of school.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of adolescent girls and young women (AGYW) who were tested for HIV and received their results during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 58.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 58.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 58.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 58.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 0.53.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 0.53.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 0.53.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 0.53.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <comment>
            <narrative>Numerator: 36597.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 28093.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3935.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 31679.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30784.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 20111.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 29570.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 31878.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27831.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 16633.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 27664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 34535.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38685.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 95527.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 103805.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 57316.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52059.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 28128.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 51553.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 38211.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 51746.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 27850; Denominator: 51746; Percentage: 53.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 51368; Denominator: 51746; Percentage: 99.27%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for adolescents and youth, in and out of school.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="9.44">
          <comment>
            <narrative>Numerator: 455877; Denominator: 4831221.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="10">
            <comment>
              <narrative>Numerator: 16603; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="2.8">
            <comment>
              <narrative>Numerator: 4608; Denominator: 166033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 24905; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="15.7">
            <comment>
              <narrative>Numerator: 26086; Denominator: 166033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="20">
            <comment>
              <narrative>Numerator: 33207; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="14.2">
            <comment>
              <narrative>Numerator: 23559; Denominator: 166033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 49810; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="24.3">
            <comment>
              <narrative>Numerator: 40338; Denominator: 166033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="53.5">
            <comment>
              <narrative>Numerator: 88885; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="48.5">
            <comment>
              <narrative>Numerator: 80452; Denominator: 166030.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="53.53">
            <comment>
              <narrative>Numerator: 88885; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="38.4">
            <comment>
              <narrative>Numerator: 63843; Denominator: 166030.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="53.53">
            <comment>
              <narrative>Numerator: 88885; Denominator: 166033.</narrative>
            </comment>
          </target>
          <actual value="48.5">
            <comment>
              <narrative>Numerator: 80452; Denominator: 166030.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women (AGYW) using PrEP</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for adolescents and youth, in and out of school.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women (AGYW) using PrEP</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="0.03">
          <comment>
            <narrative>Numerator: 1317; Denominator: 4463936.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="5">
            <comment>
              <narrative>Numerator: 1076; Denominator: 21518.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 5; Denominator: 21518.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="6">
            <comment>
              <narrative>Numerator: 2582; Denominator: 43046.</narrative>
            </comment>
          </target>
          <actual value="8">
            <comment>
              <narrative>Numerator: 3425; Denominator: 43046.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="12">
            <comment>
              <narrative>Numerator: 5164; Denominator: 43046.</narrative>
            </comment>
          </target>
          <actual value="9.5">
            <comment>
              <narrative>Numerator: 4080; Denominator: 43046.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 11520; Denominator: 76798.</narrative>
            </comment>
          </target>
          <actual value="7">
            <comment>
              <narrative>Numerator: 5392; Denominator: 76798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="18">
            <comment>
              <narrative>Numerator: 13824; Denominator: 76798.</narrative>
            </comment>
          </target>
          <actual value="20.8">
            <comment>
              <narrative>Numerator: 15940; Denominator: 76798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="18">
            <comment>
              <narrative>Numerator: 13824; Denominator: 76798.</narrative>
            </comment>
          </target>
          <actual value="20.8">
            <comment>
              <narrative>Numerator: 15940; Denominator: 76798.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of newly diagnosed people linked to HIV care (individual linkage)</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of newly diagnosed people linked to HIV care (individual linkage)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="79" />
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 2690; Denominator: 2989.</narrative>
            </comment>
          </target>
          <actual value="63.8">
            <comment>
              <narrative>Numerator: 496; Denominator: 778.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 2989; Denominator: 3321.</narrative>
            </comment>
          </target>
          <actual value="34.9">
            <comment>
              <narrative>Numerator: 708; Denominator: 2030.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 10123; Denominator: 11247.</narrative>
            </comment>
          </target>
          <actual value="59.1">
            <comment>
              <narrative>Numerator: 1434; Denominator: 2427.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 10123; Denominator: 11247.</narrative>
            </comment>
          </target>
          <actual value="59.1">
            <comment>
              <narrative>Numerator: 1434; Denominator: 2427.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T15:32:23+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-AFSA-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2022-30-Sep-2025)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, AIDS Foundation South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Reach all key and vulnerable populations with customised and targeted interventions; Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions; Implement the 95-95-95 strategy for HIV; Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities; To provide an enabling environment to increase access to health services by key and vulnerable populations; Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion; Implement economic strengthening programmes with a focus on youth and sex workers in priority focus districts; Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>AIDS Foundation South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-AFSAP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-04-01" />
    <activity-date type="2" iso-date="2022-04-01" />
    <activity-date type="3" iso-date="2025-09-30" />
    <activity-date type="4" iso-date="2025-09-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="54.58">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="44.16">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="1.26">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="3.38">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="db409d6f-4960-4f12-859f-6ad60fa29f5a" percentage="0.83">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Addressing stigma, discrimination and violence</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="29.13">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="4cda1636-6187-4ff6-8ed5-1fcceeb830bf" percentage="1.5">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="1.1">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="e5a28ba0-ab59-4fc0-aba6-e677caad3c6c" percentage="1.32">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Gender-based violence prevention and post violence care</narrative>
        </description>
      </budget-item>
      <budget-item code="d114003b-2059-4703-bbdf-e540a4be0418" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
        </description>
      </budget-item>
      <budget-item code="dca7e9d2-7860-49a4-8fb9-9fe629cd8d8c" percentage="0.74">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="7eb04704-e70b-48cf-94f5-ca1a78006662" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="7.63">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="a90c4f80-192f-4c1b-a9c0-978c47b6fe31" percentage="0.37">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Social protection interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0597f88b-5b88-4b47-8d91-6f7889b4f36f" percentage="0.2">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="0d76926d-3ff4-4be9-b57c-a4cbfd9a134f" percentage="0.47">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="fe7b40b4-5c8d-41e2-b78b-e98fa68cabe7" percentage="0.33">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="3980356a-cb5d-41ef-9ac0-654bcf4991e7" percentage="0.2">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="1f63d5bb-7cf1-4ecd-a1a0-6f951b7f88a7" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="2.2">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="3.05">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="582a5bc6-226b-4ea9-9391-54880da66119" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="22.79">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="2.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="792f3049-9f2b-41ae-a2df-af58779797ea" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="4.78">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="2.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="11.54">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="50fdc11d-9e93-4dfb-96be-056a3a7d33e7" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; HRH policy and governance</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="1.16">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0f5fc809-4d67-4e72-bef8-47081ced005b" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Others</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">18451291.82</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">29983221.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">31797574.55</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">21313901.26</value>
    </budget>
    <capital-spend percentage="5.59" />
    <transaction ref="76ff424c-b423-4306-be64-1bc181914a21">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-05" />
      <value currency="USD" value-date="2022-07-05">58714084.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd3573a6-c07f-4736-9248-2ba3021ec25f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">6770673.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9fcf2d35-c8a8-49c6-83b8-4bf90b53d6f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">7696335.18</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aea76f21-d103-406f-93f0-270aa2b52df4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">1654404.45</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bcfd1f84-e348-448e-81da-223d7c267dfe">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-21" />
      <value currency="USD" value-date="2023-02-21">4748833.56</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2e1f7df4-ed30-4605-8fb8-9580ac69d32a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-19" />
      <value currency="USD" value-date="2023-05-19">1742202.76</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e2bf3428-96ca-4f5e-817c-c0ff6ef45ec0">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-19" />
      <value currency="USD" value-date="2023-05-19">3634530.26</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34e3cd3d-093f-4e14-b860-9cddcd8e4de9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">4332747.89</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3cf2d5d7-311c-45b6-a92f-4a6f81d786f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">1487961.03</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2603b19c-fd48-406b-9ab0-5ee7708a73df">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">741774.74</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="84a1744c-7ca3-4ec4-ac67-81a455f54d15">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">5632956.74</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="91beb248-d08c-40ad-bb72-974a4541ca50">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-13" />
      <value currency="USD" value-date="2023-12-13">49673708.76</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="931e6015-7a92-4f38-8f1f-917458962601">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-13" />
      <value currency="USD" value-date="2023-12-13">-16374695.15</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a777d2e7-54a2-4e47-b03b-12113e589655">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">8661599.65</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c7558dfa-6eb8-4d2d-b333-b59bca33b160">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-01" />
      <value currency="USD" value-date="2024-03-01">2554103.41</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9543d97d-9d1c-4901-932a-c9307e4667de">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-01" />
      <value currency="USD" value-date="2024-03-01">1342865.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4f88e17d-3d43-4b91-9e97-c386f2a8c3cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-04" />
      <value currency="USD" value-date="2024-04-04">8230673.14</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ea80fe0-961e-43c5-9261-0300015398eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-30" />
      <value currency="USD" value-date="2024-05-30">12619869.96</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="63b9a65f-aae1-45fb-9d7f-9ba864169525">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-11-14" />
      <value currency="USD" value-date="2024-11-14">40276.43</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="18bbe820-b356-48d1-865c-b9456aded3d1">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-18" />
      <value currency="USD" value-date="2024-11-18">-40276.43</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b2122c9f-b3ec-4f6d-8915-2e7b87788928">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-07" />
      <value currency="USD" value-date="2024-12-07">-20161566.01</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="709e4ebd-1bca-48cb-a421-56e45cd12d27">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-07" />
      <value currency="USD" value-date="2024-12-07">19563676.48</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cdf9d6f0-fc77-4713-8a70-e4ac6aa3af1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-10" />
      <value currency="USD" value-date="2024-12-10">8536794.22</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f45f8b5c-46db-487c-8f49-68cda8e5052e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">5522168.67</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="660d0785-e857-4dc0-8931-31614f980580">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">3474732.10</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a208a0bd-e5a2-4923-a760-5fdae3f6c6c2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">-2029981.49</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="527b0fc3-8e3c-420c-a481-bb9a16b943b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">4854327.56</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cd1d52e-b74d-4d06-a8d4-e43ca19d8cf3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">4253154.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0947d7b0-2b53-4f65-b256-f54adfed59a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">601172.66</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8ce53ab1-e711-4c1d-b51a-8c01e1364620">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-19" />
      <value currency="USD" value-date="2025-12-19">195964.77</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-AFSAP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a69fe03-34c2-4ede-a24b-4b25756e977e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">195964.77</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-AFSAP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ZAF-C-AFSAP03-EXP-20230331">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-03-31" />
      <value currency="USD" value-date="2023-03-31">26149110.04</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP03, Apr 2022 to Mar 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP03-EXP-20240331">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-03-31" />
      <value currency="USD" value-date="2024-03-31">30205297.85</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP03, Apr 2023 to Mar 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-AFSAP03-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">36290330.70</value>
      <description>
        <narrative>Expenditure reported by AIDS Foundation South Africa for ZAF-C-AFSAP03, Apr 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>AIDS Foundation South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ZAF/2021/TB_HIV/en/ZAF-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - TB/HIV - South Africa - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1042-ZAF-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP Other-1: Number of male sexual partners that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>KP Other-1: Number of male sexual partners that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 96186.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45507.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28136.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 18203.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4351.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 27304.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 59070.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52764.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 29535.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28026.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 29535.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24738.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 63793.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 106322.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 77844.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 42529.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 35072.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 42529.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25721; Denominator: 42529; Percentage: 60.48%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 38685; Denominator: 166033; Percentage: 23.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 217766; Denominator: 219972; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 217766; Denominator: 219972; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 217766; Denominator: 219972; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 217766; Denominator: 219972; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 217766; Denominator: 219972; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 2206; Denominator: 219972; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 2206; Denominator: 219972; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 2206; Denominator: 219972; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 2206; Denominator: 219972; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 2206; Denominator: 219972; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 108026; Denominator: 407323; Percentage: 27%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 49640; Denominator: 407323; Percentage: 12.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 305; Denominator: 49640; Percentage: 0.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 42855; Denominator: 49640; Percentage: 86.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 148758; Denominator: 407323; Percentage: 37%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 124721; Denominator: 407323; Percentage: 30.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 148758; Denominator: 407323; Percentage: 37%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 124721; Denominator: 407323; Percentage: 30.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 124065; Denominator: 124721; Percentage: 99.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 656; Denominator: 124721; Percentage: 0.53%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 162748.9; Denominator: 407323.76; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 141757; Denominator: 407324; Percentage: 34.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 141291; Denominator: 141757; Percentage: 99.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 466; Denominator: 141757; Percentage: 0.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 178864.6; Denominator: 407323.8; Percentage: 44%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 145947; Denominator: 407324; Percentage: 35.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 178864.61; Denominator: 407323.76; Percentage: 44%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 145947; Denominator: 407324; Percentage: 35.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 145447; Denominator: 145947; Percentage: 99.66%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 500; Denominator: 145947; Percentage: 0.34%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 229337; Denominator: 407323.8; Percentage: 56%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 148430; Denominator: 407324; Percentage: 36.44%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 199230.8; Denominator: 407323.76; Percentage: 49%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 229336.97; Denominator: 407323.76; Percentage: 56%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 148430; Denominator: 407324; Percentage: 36.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 148082.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 348.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 229336.97; Denominator: 407323.76; Percentage: 56%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 136716; Denominator: 229337; Percentage: 59.61%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 13131; Denominator: 40149; Percentage: 32.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12834; Denominator: 19097; Percentage: 67.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12834; Denominator: 19097; Percentage: 67.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12834; Denominator: 19097; Percentage: 67.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12834; Denominator: 19097; Percentage: 67.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12834; Denominator: 19097; Percentage: 67.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 6271; Denominator: 19097; Percentage: 32.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 6271; Denominator: 19097; Percentage: 32.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 6271; Denominator: 19097; Percentage: 32.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 6271; Denominator: 19097; Percentage: 32.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 6271; Denominator: 19097; Percentage: 32.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 18757; Denominator: 19097; Percentage: 98.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 18757; Denominator: 19097; Percentage: 98.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 18757; Denominator: 19097; Percentage: 98.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 18757; Denominator: 19097; Percentage: 98.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 18757; Denominator: 19097; Percentage: 98.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 257; Denominator: 19097; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 257; Denominator: 19097; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 257; Denominator: 19097; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 257; Denominator: 19097; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 257; Denominator: 19097; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 17806; Denominator: 19097; Percentage: 93.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 17806; Denominator: 19097; Percentage: 93.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 17806; Denominator: 19097; Percentage: 93.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 17806; Denominator: 19097; Percentage: 93.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 17806; Denominator: 19097; Percentage: 93.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 958; Denominator: 19097; Percentage: 5.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 958; Denominator: 19097; Percentage: 5.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 958; Denominator: 19097; Percentage: 5.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 958; Denominator: 19097; Percentage: 5.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 958; Denominator: 19097; Percentage: 5.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 90; Denominator: 19097; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 90; Denominator: 19097; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 90; Denominator: 19097; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 90; Denominator: 19097; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 90; Denominator: 19097; Percentage: 0.47%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 13716; Denominator: 21515; Percentage: 64%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 15100; Denominator: 21515; Percentage: 70.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5222; Denominator: 15738; Percentage: 33.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 10470; Denominator: 15738; Percentage: 66.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 316; Denominator: 15100; Percentage: 2.09%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 14784; Denominator: 15100; Percentage: 97.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 249; Denominator: 15738; Percentage: 1.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 15394; Denominator: 15738; Percentage: 97.81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 47; Denominator: 15738; Percentage: 0.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 16136; Denominator: 21515; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19463; Denominator: 21515; Percentage: 90.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 16136; Denominator: 21515; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19463; Denominator: 21515; Percentage: 90.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 13629; Denominator: 20273; Percentage: 67.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 6644; Denominator: 20273; Percentage: 32.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 18883; Denominator: 20273; Percentage: 93.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 529; Denominator: 20273; Percentage: 2.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 19062; Denominator: 20273; Percentage: 94.03%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 401; Denominator: 20273; Percentage: 1.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 57; Denominator: 20273; Percentage: 0.28%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 16974; Denominator: 22189; Percentage: 77%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21102; Denominator: 22189; Percentage: 95.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 14502; Denominator: 21928; Percentage: 66.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 7426; Denominator: 21928; Percentage: 33.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 20316; Denominator: 21928; Percentage: 92.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 661; Denominator: 21928; Percentage: 3.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 20822; Denominator: 21928; Percentage: 94.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 280; Denominator: 21928; Percentage: 1.28%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 137; Denominator: 21928; Percentage: 0.62%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 18860; Denominator: 22189; Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28826; Denominator: 22189; Percentage: 129.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 18860; Denominator: 22189; Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28826; Denominator: 22189; Percentage: 129.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 20510; Denominator: 30033; Percentage: 68.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 9523; Denominator: 30033; Percentage: 31.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 27519; Denominator: 28826; Percentage: 95.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1148; Denominator: 28826; Percentage: 3.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 28496; Denominator: 28826; Percentage: 98.86%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 330; Denominator: 28826; Percentage: 1.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 177; Denominator: 28826; Percentage: 0.61%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 19775; Denominator: 22887; Percentage: 86%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 20599; Denominator: 22887; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30731; Denominator: 22887; Percentage: 134.27%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 20599; Denominator: 22887; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30731; Denominator: 22887; Percentage: 134.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 22286.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 9371.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 29745.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 826.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 30559.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 172.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 180.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 20599; Denominator: 22887; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24701; Denominator: 20599; Percentage: 119.91%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="24.3">
          <comment>
            <narrative>Numerator: 40338; Denominator: 166033.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 129603; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="47">
            <comment>
              <narrative>Numerator: 101421; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="56">
            <comment>
              <narrative>Numerator: 121953; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="23">
            <comment>
              <narrative>Numerator: 49633; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 129603; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="47">
            <comment>
              <narrative>Numerator: 101421; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 151204; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 123634; Denominator: 151204.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 140403; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="50.9">
            <comment>
              <narrative>Numerator: 110016; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 151204; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 123634; Denominator: 151204.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 172804; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="59.94">
            <comment>
              <narrative>Numerator: 129463; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 162004; Denominator: 216005.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 172804; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="59.94">
            <comment>
              <narrative>Numerator: 129463; Denominator: 216005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 172804; Denominator: 216005.</narrative>
            </comment>
          </target>
          <actual value="63.46">
            <comment>
              <narrative>Numerator: 109656; Denominator: 172804.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of eligible sex workers who initiated oral antiretroviral PrEP during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of eligible sex workers who initiated oral antiretroviral PrEP during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="12.71">
          <comment>
            <narrative>Numerator: 8099; Denominator: 63730.05.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="20.99">
            <comment>
              <narrative>Numerator: 2429; Denominator: 11570.</narrative>
            </comment>
          </target>
          <actual value="25.9">
            <comment>
              <narrative>Numerator: 2998; Denominator: 11570.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="21.1">
            <comment>
              <narrative>Numerator: 5297; Denominator: 25140.</narrative>
            </comment>
          </target>
          <actual value="28.9">
            <comment>
              <narrative>Numerator: 7268; Denominator: 25140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="21">
            <comment>
              <narrative>Numerator: 2868; Denominator: 13570.</narrative>
            </comment>
          </target>
          <actual value="31.5">
            <comment>
              <narrative>Numerator: 4270; Denominator: 13570.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="27">
            <comment>
              <narrative>Numerator: 3788; Denominator: 13990.</narrative>
            </comment>
          </target>
          <actual value="32">
            <comment>
              <narrative>Numerator: 4472; Denominator: 13990.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="27.7">
            <comment>
              <narrative>Numerator: 8073; Denominator: 29153.</narrative>
            </comment>
          </target>
          <actual value="30.2">
            <comment>
              <narrative>Numerator: 9437; Denominator: 31266.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="28">
            <comment>
              <narrative>Numerator: 4285; Denominator: 15163.</narrative>
            </comment>
          </target>
          <actual value="28.7">
            <comment>
              <narrative>Numerator: 4965; Denominator: 17276.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 6125; Denominator: 15473.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="41.3">
            <comment>
              <narrative>Numerator: 12611; Denominator: 30537.</narrative>
            </comment>
          </target>
          <actual value="38.24">
            <comment>
              <narrative>Numerator: 10980; Denominator: 28710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="43">
            <comment>
              <narrative>Numerator: 6486; Denominator: 15064.</narrative>
            </comment>
          </target>
          <actual value="42.63">
            <comment>
              <narrative>Numerator: 5373; Denominator: 12605.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="43">
            <comment>
              <narrative>Numerator: 6486; Denominator: 15064.</narrative>
            </comment>
          </target>
          <actual value="56.06">
            <comment>
              <narrative>Numerator: 3636; Denominator: 6486.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 40149; Denominator: 41463; Percentage: 96.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 45417; Denominator: 58207; Percentage: 78.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 45417; Denominator: 58207; Percentage: 78.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 45417; Denominator: 58207; Percentage: 78.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 45417; Denominator: 58207; Percentage: 78.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 45417; Denominator: 58207; Percentage: 78.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 12818; Denominator: 58207; Percentage: 22.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 12818; Denominator: 58207; Percentage: 22.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 12818; Denominator: 58207; Percentage: 22.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 12818; Denominator: 58207; Percentage: 22.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 12818; Denominator: 58207; Percentage: 22.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 57268; Denominator: 58207; Percentage: 98.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 57268; Denominator: 58207; Percentage: 98.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 57268; Denominator: 58207; Percentage: 98.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 57268; Denominator: 58207; Percentage: 98.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 57268; Denominator: 58207; Percentage: 98.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 556; Denominator: 58207; Percentage: 0.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 556; Denominator: 58207; Percentage: 0.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 556; Denominator: 58207; Percentage: 0.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 556; Denominator: 58207; Percentage: 0.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 556; Denominator: 58207; Percentage: 0.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 437; Denominator: 58207; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 437; Denominator: 58207; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 437; Denominator: 58207; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 437; Denominator: 58207; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Transgender" />
          <comment>
            <narrative>Numerator: 437; Denominator: 58207; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45000; Denominator: 45584; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 44588; Denominator: 45584; Percentage: 97.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 35187; Denominator: 44588; Percentage: 78.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 10228; Denominator: 44588; Percentage: 22.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 43913; Denominator: 44588; Percentage: 98.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 165; Denominator: 44588; Percentage: 0.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 511; Denominator: 44588; Percentage: 1.15%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45000; Denominator: 45584; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 55391; Denominator: 45584; Percentage: 121.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45000; Denominator: 45584; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 55391; Denominator: 45584; Percentage: 121.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 44913; Denominator: 55391; Percentage: 81.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 13895; Denominator: 55391; Percentage: 25.09%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 54035; Denominator: 55391; Percentage: 97.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1096; Denominator: 55391; Percentage: 1.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 316; Denominator: 55391; Percentage: 0.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57505; Denominator: 45584; Percentage: 126.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 45370; Denominator: 58864; Percentage: 77.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 13518; Denominator: 58864; Percentage: 22.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 55878; Denominator: 58885; Percentage: 94.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1173; Denominator: 58885; Percentage: 1.99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 498; Denominator: 58885; Percentage: 0.85%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67722; Denominator: 45584; Percentage: 148.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67722; Denominator: 45584; Percentage: 148.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 54966; Denominator: 69124; Percentage: 79.52%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 16049; Denominator: 69124; Percentage: 23.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 65182; Denominator: 67722; Percentage: 96.25%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1992; Denominator: 67722; Percentage: 2.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 635; Denominator: 67722; Percentage: 0.94%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 63719; Denominator: 45584; Percentage: 139.78%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 63719; Denominator: 45584; Percentage: 139.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 51371.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 14078.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 61843.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1424.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transgender" />
            <comment>
              <narrative>Numerator: 519.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45584; Denominator: 45584; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52597; Denominator: 45584; Percentage: 115.38%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>YP-Other 1: Percentage of eligible other vulnerable populations who initiated oral antiretroviral PrEP during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>YP-Other 1: Percentage of eligible other vulnerable populations who initiated oral antiretroviral PrEP during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="7.41">
          <comment>
            <narrative>Numerator: 3191; Denominator: 43046.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="9.6">
            <comment>
              <narrative>Numerator: 23710; Denominator: 247577.</narrative>
            </comment>
          </target>
          <actual value="10.1">
            <comment>
              <narrative>Numerator: 17326; Denominator: 171659.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="8">
            <comment>
              <narrative>Numerator: 8566; Denominator: 104197.</narrative>
            </comment>
          </target>
          <actual value="12">
            <comment>
              <narrative>Numerator: 5869; Denominator: 48869.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="11">
            <comment>
              <narrative>Numerator: 15144; Denominator: 143380.</narrative>
            </comment>
          </target>
          <actual value="9.3">
            <comment>
              <narrative>Numerator: 11457; Denominator: 122790.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="10.9">
            <comment>
              <narrative>Numerator: 35748; Denominator: 327894.</narrative>
            </comment>
          </target>
          <actual value="10.7">
            <comment>
              <narrative>Numerator: 30460; Denominator: 283798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="11">
            <comment>
              <narrative>Numerator: 17052; Denominator: 156261.</narrative>
            </comment>
          </target>
          <actual value="9.8">
            <comment>
              <narrative>Numerator: 13719; Denominator: 140004.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="11">
            <comment>
              <narrative>Numerator: 18696; Denominator: 171633.</narrative>
            </comment>
          </target>
          <actual value="11.6">
            <comment>
              <narrative>Numerator: 16741; Denominator: 143794.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="11">
            <comment>
              <narrative>Numerator: 20526; Denominator: 191198.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="10.7">
            <comment>
              <narrative>Numerator: 43932; Denominator: 411397.</narrative>
            </comment>
          </target>
          <actual value="10.46">
            <comment>
              <narrative>Numerator: 32693; Denominator: 312428.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="11">
            <comment>
              <narrative>Numerator: 23406; Denominator: 220199.</narrative>
            </comment>
          </target>
          <actual value="11.02">
            <comment>
              <narrative>Numerator: 16183; Denominator: 146880.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="11">
            <comment>
              <narrative>Numerator: 23406; Denominator: 220199.</narrative>
            </comment>
          </target>
          <actual value="80.36">
            <comment>
              <narrative>Numerator: 18808; Denominator: 23406.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>CSS-Other 1: Percentage of CSOs capacitated through the program that successfully attracted a small grant (any donor) and has begun implementation</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>CSS-Other 1: Percentage of CSOs capacitated through the program that successfully attracted a small grant (any donor) and has begun implementation</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="46">
          <comment>
            <narrative>Numerator: 23; Denominator: 50.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="76.9">
            <comment>
              <narrative>Numerator: 10; Denominator: 13.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="52">
            <comment>
              <narrative>Numerator: 13; Denominator: 25.</narrative>
            </comment>
          </target>
          <actual value="52">
            <comment>
              <narrative>Numerator: 13; Denominator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="76.9">
            <comment>
              <narrative>Numerator: 10; Denominator: 13.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 13; Denominator: 26.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of community organizations that received a pre-defined package of training</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of community organizations that received a pre-defined package of training</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="50" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="25" />
          <actual value="27" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="26" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="26" />
          <actual value="26" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 1: Number of police and other law enforcement officers in Global Fund-supported districts reached by training  program</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>HR-Other 1: Number of police and other law enforcement officers in Global Fund-supported districts reached by training  program</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="293" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="400" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="1000" />
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="600" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="1000" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="2000" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="1000" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="2000" />
          <actual value="861" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="1200" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="800" />
          <actual value="84" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 2: Number of analytical reports generated from a functional national human rights reporting system on human rights violations based on inputs from local level users</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>HR-Other 2: Number of analytical reports generated from a functional national human rights reporting system on human rights violations based on inputs from local level users</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="2" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="2" />
          <actual value="2" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="4" />
          <actual value="2" />
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="2" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="2" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="2" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="4" />
          <actual value="2" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="2" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="2" />
          <actual value="2" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>